Article
Intratumoural oncolytic HSV-1 reshapes the local and systemic immune landscape through CD8 <sup>⁺</sup> T cell reprogramming
2026-04-10
Abstract excerpt
Most oncolytic viruses are delivered by intratumoural injection, and local administration can induce regression of both injected and distant tumours in mice and patients. However, the mechanisms by which local viral infection reprograms systemic immunity remain poorly understood. Here we show that intratumoural RP1, an oncolytic HSV-1 encoding GM-CSF and GALV-GP-R ⁻ , drives regression of injected and uninjected...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 219f0a3d-4318-55dd-a852-e512db6512d9
- DOI
- 10.64898/2026.04.07.716986
